Search | IOVS | ARVO Journals

View

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Adjuvant ursodeoxycholic acid for retinal detachment : a potential neuroprotective therapy.

Alejandra Daruich; Emilie Picard; Marta Zola; Hugues Henry; Jeffrey H Boatright; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2795. doi:

ARVO Annual Meeting Abstract June 2017

Chronic central serous chorioretinopathy treated with mineralocorticoid-receptor antagonists: long-term follow up.

Marta Zola; Alejandra Daruich; Alexandre Matet; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5931. doi:

ARVO Annual Meeting Abstract June 2017

Risk factors for recurrences in central serous chorioretinopathy

Alexandre Matet; Alejandra Daruich; Marta Zola; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2965. doi:

ARVO Annual Meeting Abstract September 2016

Central serous chorioretinopathy in women

Priyanka Sanghi; Marta Zola; Deepthy Menon; Namritha Patrao; Jayashree Ramu; Philip Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2157. doi:

ARVO Annual Meeting Abstract September 2016

Evolution of Short-wavelength Autofluorescence changes in Central Serous Chorioretinopathy over 12 months.

Marta Zola; Priyanka Sanghi; Namritha Patrao; Deepthy Menon; Philip Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3398. doi:

ARVO Annual Meeting Abstract September 2016

Significance of Choroidal Hyper-reflective foci visualised on Enhanced Depth Imaging in Central Serous Chorioretinopathy

Namritha Valerie Patrao; Deepthy Menon; Marta Zola; Priyanka Sanghi; Luke Nicholson; Philip Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4234. doi:

Advertisement